Search NLS News

Nordic Life Science asked the Interim Director General about strengths and challenges within Swedish life sciences, her message to the new government in Sweden, and about strengthening and showcasing the Nordic life science region. Frida Lawenius, who has been Deputy Director General of SwedenBIO since January 2020, brings experience from both political influence and strategic […]

Three members of the company’s Board, Solveig Hellebust, Jean Pierre Bizzari and Thomas Ramdahl, has decided to step down from the Board with immediate effect. Following the decisions to discontinue the PARADIGME study for Betalutin, restructure the company and appoint Carnegie Investment Bank to explore strategic options, the three members have taken this decision. Read […]

Life science applications captured Richard Johnsson’s interest early on and today, as Head of R&D Operations at Red Glead Discovery, he enjoys finding drug discovery solutions, helping clients bring new therapies to market, and being part of the development of the field. Richard Johnsson’s way into the field of life sciences was organic chemistry. His […]

AlzeCure Pharma has received new data from the clinical phase I study (multiple ascending dose, MAD) with repeated dosing of the drug candidate ACD856, which is being developed against Alzheimer’s disease and other indications with cognitive dysfunction. New data from a planned exploratory analysis of the MAD study show that ACD856 increases EEG activity in […]

Frida Lawenius, who has been Deputy Director General of SwedenBIO since January 2020, brings experience from both political influence and strategic development into her new role. ”Frida Lawenius is an experienced leader who is well driven in the life science industry’s needs and in the daily operations of SwedenBIO’s office. She also has cultivated well-functioning […]

The company has become a partner of EHDEN, a private-public partnership that is building a large-scale, federated network of data sources standardized to a common data model. Lundbeck now joins the 11 public partners, and 12 industry partners, adding our expertise, resources, and support in creating an ecosystem for working with real world data across […]

Alligator Bioscience has announced a poster presentation on the OPTIMIZE-1 Phase 1b/2 trial of mitazalimab in combination with modified FOLFIRINOX in first-line metastatic pancreatic cancer with the company’s lead asset mitazalimab at the 2022 AACR Special Conference on Pancreatic Cancer, being held in Boston September 13-16. The presentation, entitled “Mitazalimab (CD40 agonist) in combination with […]

In this 108-page issue we have chosen to take a closer look at five Nordic innovation districts, at different development stages and with different challenges and life science offerings, but with the same goal of facilitating knowledge transfer and spurring innovation and life science growth in our region and beyond. In addition, we present our […]

The two companies have entered a new strategic collaboration to combine Microsoft’s computational services, cloud and artificial intelligence with Novo Nordisk’s drug discovery, development and data science capabilities. Through the partnership, Microsoft is providing AI technology, foundational science models and expertise and is working alongside Novo Nordisk’s data scientists and domain experts from early research […]

The company has received approval for its pulse biopsy system NeoNavia from the US Food and Drug Administration, FDA. “The FDA approval for NeoNavia is a major milestone for NeoDynamics and a stamp of quality for both the product and NeoDynamics as a whole,” says Anna Eriksrud, CEO of NeoDynamics, in NeoDynamics’ press release. “The […]